Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers
BMC Cancer Apr 13, 2018
Defossez G, et al. - Researchers determined the influence of the participation in screening programme according to the mode of detection on the early diagnosis, treatment, and specific survival outcomes in women with breast cancer. Using the Kaplan–Meier method and Cox proportional hazard models, specific survival rates were assessed in three groups of breast cancer patients: the screening programme (SP), interval cancer (IC), and non-screening programme detected cancer (NSP) groups. Relative to screen-detected cancers, more aggressive features were shown by interval cancers. However, compared to non-screen detected cancers, interval cancers were diagnosed at a less advanced stage. Early treatment seemed to benefit women who participated in the screening process despite having cancers missed by the screening programme.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries